COMPANY OVERVIEW

Cresco Labs is one of the largest public, vertically integrated, multistate operators in the cannabis industry. Our portfolio of in-house cultivated and manufactured brands features some of the highest quality, most awarded and most popular cannabis products in America. With dozens of locations nationwide, our owned and operated Sunnyside® dispensaries provide a welcoming, positive, judgement-free place to shop for anyone at any point on their cannabis journey.

Founded in 2013, Cresco Labs’ mission is to normalize and professionalize cannabis through our passionate employees. As stewards of the cannabis industry, our teams are constantly focused on supporting the needs of our fellow colleagues, consumers, customers, and communities alike. With a focus on Social Equity and Educational Development, our SEEDTM initiative ensures that our company reflects the communities in which we serve, ensuring equal opportunity for all to have the knowledge and resources to work in and own businesses in cannabis.

At Cresco Labs, we aim to revolutionize and lead the nation’s cannabis industry with a focus on quality and consistency of product, and to bring legitimacy to the industry with the highest level of integrity and professionalism.

If you’re interested in joining our mission, click the below links to join our team today!

MISSION STATEMENT

At Cresco, we aim to lead the nation’s cannabis industry with a focus on regulatory compliance, product consistency, and customer satisfaction. Our operations bring legitimacy to the cannabis industry by acting with the highest level of integrity, strictly adhering to regulations, and promoting the clinical efficacy of cannabis. As Cresco grows, we will operate with the same level of professionalism and precision in each new market we move in to.

SCHEDULE

Monday - Friday, 7:15am - 3:45pm

CORE JOB DUTIES

Executing tasks assigned by department leadership.
Measuring, packaging, and labeling products
Compares product with product standards to ensure quality.
Maintaining a sanitary work environment
Safely transport products from workspace to storage area
Ensure that all functions are performed to the highest standard of quality and compliance

REQUIRED EXPERIENCE, EDUCATION AND SKILLS

1 year (2-3 years preferable) of hands-on experience in a factory, production or manufacturing fast-paced environment with measurable goals and working standards, preferred.
Strong attention to detail and ability to adhere to strict policies and procedure
Ability to measure, package and label in a precise manner
Effective time-management skills and ability to multi-task
Ability to work in a fast-paced, changing and challenging environment
Proficiency in windows-based software and point of sale applications a plus
Requires work around plant material, which could include exposure to plant pollen and/or dust.
Requires ability to sit, stand, kneel, and/or do repetitive actions with your hands for long periods of time.
Requires ability to lift up to 50 lbs to torso level.

In accordance with any local and state compensation laws, the compensation listed is the current estimated range for the position. Final offer details and future compensation may be determined by multiple factors including but not limited to, geographic location, market compensation data, skills, experience, and other relevant factors. For questions about this please discuss with your recruiter during the interview process.

Pay Range

$17—$17 USD

BENEFITS

Cresco Labs is proud to offer eligible employees a robust offering of benefits including, major medical, dental and vision insurance, a 401(K)-match program, FSA/HSA programs, LTD/STD options, life insurance and AD&D. We also offer eligible employees paid holidays and paid time off. Other rewards may include annual discretionary bonuses, stock options as well as participation in our employee discount program. Benefits eligibility for permanent positions may vary by full-time or part-time roles, location, or position.

ADDITIONAL REQUIREMENTS

Must be 21 years of age or older to apply
Must comply with all legal or company regulations for working in the industry
The company does not offer employment-based visa sponsorship for this role or any other position, now or in the future. Applicants must be legally authorized to work in the United States on a permanent basis without the need for current or future sponsorship at any time.

Cresco Labs is an Equal Opportunity Employer and all applicants will be considered without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran, or disability status.

California Consumer Privacy Act (“CCPA”) Notice to Applicants:

Please read the California Employee Privacy Notice (“CA Privacy Notice”) regarding Sunnyside* and its affiliate Cresco Labs’ policies pertaining to the collection, use, and disclosure of personal information. This CA Privacy Notice supplements the information contained in the Sunnyside* Privacy Policy and applies to California resident employees and job applicants. Applicants with disabilities may access this notice in an alternative format by contacting [email protected]

Reporting a Scam:

Cresco Labs is aware of fictitious employment offers being circulated from various sources. Many of these schemes consist of an alleged offer of employment with Cresco Labs with the intention of gaining personal information, including payment and/or banking information. Be aware that fraudulent job offers and correspondence may appear legitimate: they may feature a Cresco Labs logo, they may appear to originate from an official-looking email address or web site, or they may be sent by individuals purporting to represent Cresco Labs or an entity which includes the word Cresco Labs in its name.

Please note that Cresco Labs does not ask for payment or personal banking information as a condition of employment. Any personal information is requested for payroll or state badging purposes only. Applications can be securely submitted through our career’s pages.

We are working diligently to block this from happening. Beware if an offer of employment looks too good to be true. Never divulge personal and banking information or send money if you are unsure of the authenticity of an email or other communication in the name of Cresco Labs.

If you are in doubt, please contact us at [email protected]with questions.

Pay Range 17 - 17 USD

About the company

Cresco Labs grows, processes, and retails cannabis products in eleven states, serving adult-use and medical markets. Its products come from its own cultivation and manufacturing facilities and are sold under a portfolio of trusted brands to ensure consistency. It differentiates itself through vertical integration—grower, processor, retailer—operating in high-demand, well-regulated markets to maintain quality and supply. Its goal is to expand market presence while upholding responsible practices, collaborating with governments, using eco-friendly packaging, and delivering value to shareholders and communities.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

2013

Get referred to Cresco Labs

See people who can refer or advise you

Simplify's Take

What believers are saying

Q2 2026 revenue hit $173.3 million, up 15% sequentially and net income $15.4 million.
Q2 adjusted EBITDA reached $39.5 million, while free cash flow turned positive at $6.5 million.
September 2 PharmaCann deal added nine stores for $50 million, immediately accretive.

What critics are saying

Palomar sued on August 14, 2026, denying defense coverage for Cresco's cannabis marketing class actions.
Two May 4 class actions accuse Cresco of deceptive health claims and seek economic damages.
CFO Sharon Schuler stepped down August 2026, and replacement risk shadows Pennsylvania integration.

What makes Cresco Labs unique

Cresco's Pennsylvania integration makes it state's top medical retailer and wholesaler.
Sunnyside retail plus branded wholesale gives Cresco direct consumer and shelf access.
Needham Bank's 7.99% revolver gives Cresco conventional banking access uncommon for cannabis operators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
401(k) Company Match
401(k) Retirement Plan
Performance Bonus

Growth & Insights and Company News

6 month growth

1 year growth

2 year growth

Yahoo Finance

Oct 23rd, 2026

Cresco Labs opens 83rd dispensary in Kentucky, completing medical cannabis coverage of all 11 regions

Cresco Labs has opened Sunnyside Prestonsburg in Kentucky, its 83rd dispensary in the US. The store is at 81 Glynview Plaza in Eastern Kentucky. The opening means dispensaries now operate in all 11 regions of Kentucky's emerging medical cannabis program for the first time. "Access is the foundation of any successful medical cannabis program," said Charlie Bachtell, chief executive officer of Cresco Labs. He called the opening an important step toward making medical cannabis a practical treatment option for Eastern Kentucky patients. The dispensary offers trained Wellness Advisors and lab-tested products, including flower for vaporisation, tinctures, topicals, and edibles. Registered patients can shop in store or order online for pickup.

Financial Post

Oct 23rd, 2026

Cresco Labs celebrates Sunnyside Prestonsburg grand opening, marking major milestone for Kentucky medical cannabis.

Cresco Labs celebrates Sunnyside Prestonsburg grand opening, marking major milestone for Kentucky medical cannabis. Business Wire Published Oct 23, 2026 CHICAGO - Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), today announced the grand opening of Sunnyside Prestonsburg in Kentucky, the Company's 83rd dispensary nationwide. Sunnyside's opening marks a major milestone for Kentucky's emerging medical cannabis program, with dispensaries now operating in all 11 regions of the Commonwealth for the first time. Story continues below "Access is the foundation of any successful medical cannabis program," said Charlie Bachtell, CEO of Cresco Labs. "Kentucky continues to make meaningful progress, and we're excited to help build on that momentum. For patients in Eastern Kentucky, this is an important step toward making medical cannabis a practical, accessible treatment option." Top Stories Interested in more newsletters? Browse here. The dispensary is located in the heart of Eastern Kentucky at 81 Glynview Plaza in Prestonsburg. It offers an education-focused shopping experience, with trained Wellness Advisors available to help patients navigate a curated selection of lab-tested products, including flower for vaporization, tinctures, topicals and edibles. Registered medical cannabis patients can shop in-store or place orders online at www.sunnyside.shop for pickup. About Cresco Labs Inc. Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production, and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's, and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development, and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Forward-Looking Statements This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995 (collectively, "forward-looking statements"). Such forward-looking statements are not representative of historical facts or information or current condition but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as, 'may,' 'will,' 'should,' 'could,' 'would,' 'expects,' 'plans,' 'anticipates,' 'believes,' 'estimates,' 'projects,' 'predicts,' 'potential,' or 'continue,' or the negative of those forms or other comparable terms. The Company's forward-looking statements, including with regard to the integration of PharmaCann and the anticipated impact of the acquisition, involve known and unknown risks, uncertainties, and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under "Risk Factors" in the Company's Annual Information Form for the year ended December 31, 2025, filed on SEDAR+ and EDGAR, in other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company's forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs' shares, nor as to the Company's financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company's forward-looking statements contained herein, whether as a result of new information, any future event, or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise. View source version on businesswire.com: Mark Stortz, Interim CFO, Cresco Labs For general Cresco Labs inquiries: 312-929-0993 This advertisement has not loaded yet.

Yahoo Finance

Oct 14th, 2026

Cresco Labs shares slide 52% in a year despite Q2 swing to $16.8M profit

Cresco Labs shareholders lost 52.1% over the past year, including dividends, even as the cannabis operator swung to profit. The shares cost CA$1.85 a year ago and now trade at CA$0.9. In the second quarter of 2026, Cresco reported revenue of US$173.341m, up from US$163.624m a year earlier. Net income was US$16.796m, against a US$16.334m loss, moving net margin from a 10.0% loss to a 9.7% gain. Investors have weighed two views. The bullish case sets fair value at CA$2.15, citing new dispensaries, exits from weaker states, and tighter cost control. The bearish case sets it at CA$1.51, citing price compression, 0.3% assumed revenue growth, and 12.5% debt.

Cannabis NewsWire

Sep 4th, 2026

420 with CNW - convenience is giving an edge to entities selling marijuana.

420 with CNW - convenience is giving an edge to entities selling marijuana. September 4, 2026 Marijuana companies are increasingly betting that convenience will determine what consumers buy, as shoppers show growing interest in products that require little preparation and can fit easily into everyday routines. The shift is particularly visible among newer cannabis customers, who may be less comfortable with traditional consumption methods. An analysis of Headset data found that disposable, all-in-one vaporizers generated roughly $2.82 billion from 94.8 million units, representing annual gains of 23.8% in sales and 22.9% in volume. The average price was about $29.77. Meanwhile, cartridges, historically the biggest vape category, recorded approximately $2.89 billion in sales but declined 14.1% in sales and 8% in unit volume. Their average price was lower, at $19.66, suggesting cost alone does not explain the difference. For many buyers, simplicity appears to be more important. A similar development is occurring in pre-rolls. Infused versions reached about $1.8 billion and posted increases of 13.4% in sales and 21% in volume. Multi-unit packages are also expanding, giving brands such as Dogwalkers additional room to grow. The appeal extends beyond smoking products. Cresco Labs is preparing to introduce High Supply SLIPS, an oral marijuana pouch, through its Sunnyside stores. The product is expected to come in two flavors and offer 4-milligram and 10-milligram doses. The concept draws from the growing popularity of nicotine pouches. Philip Morris reported shipping nearly 165 million cans of Zyn during the fourth quarter of 2025, a 42% increase from a year earlier. Dana Mason, a Cresco brand manager, said demand for simpler inhalable products helped signal an opportunity for consumption methods that do not require smoking. Oral pouches could appeal to consumers at sporting venues, restaurants, and on public transportation, where lighting a joint or using a vape may not be practical. The convenience trend is also influencing hemp-derived products. According to Edibles.com president Thomas Winstanley, some consumers are incorporating THC gummies and chews into routines that resemble supplement use, while others view hemp beverages as an alternative to alcohol. Wider retail availability may further encourage experimentation. Products appearing in familiar outlets such as Total Wine and Circle K can give curious customers an alternative to visiting a dispensary. Experts expect the next stage of innovation to emphasize discretion, including tinctures, sublingual products, and other low-effort formats. As cannabis companies compete for new customers, reducing the number of steps between purchase and consumption could become an increasingly important advantage. The extent to which marijuana firms like Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) leverage this emerging trend could determine the magnitude of their sales growth over the coming years as more first-time customers shop for cannabis products. About CNW420 CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern - a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis. To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only) Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer CannabisNewsWire is powered by IBN Select A Month

Cannabis Promotions

Sep 3rd, 2026

Marijuana MSO Cresco scoops up PharmaCann Pennsylvania assets.

Marijuana MSO Cresco scoops up PharmaCann Pennsylvania assets. September 3, 2026 Cannabis Industry News Key points. * Cresco acquires PharmaCann Pennsylvania assets to expand regional footprint * Transaction positions Cresco as the top MMJ retailer and wholesaler in Pennsylvania * Deal highlights ongoing consolidation trends among major multi-state operators Multi-state operator Cresco Labs has acquired key Pennsylvania assets from rival PharmaCann, significantly expanding its footprint in the second-largest medical marijuana market in the United States. This strategic transaction establishes Cresco as the top medical cannabis retailer and wholesaler in Pennsylvania. The deal brings additional operational facilities and retail storefronts into Cresco's existing portfolio, consolidating market share in a limited-license state where vertical integration drives profitability. As consolidation accelerates across regulated state markets, large operators continue utilizing M&A strategies to capture supply chain dominance and secure consumer touchpoints. For dispensary owners and brand managers operating in the region, this shift signals a changing competitive dynamic - one where scaled operators hold distinct advantages in wholesale pricing and distribution reach. Compliance overhead and supply chain logistics will likely remain central focus areas as integration proceeds. What this means for your brand. Dispensaries and brands in Pennsylvania must prepare for increased market consolidation and stronger wholesale competition. Regional brands should focus on differentiation and strong retail partnerships to maintain shelf space against expanding MSOs.

Cresco Labs

Packaging Agent

About the job